HYBRID EVENT: Join us in person in Orlando, Florida, USA or attend virtually from anywhere.

8th Edition of Global Conference on

Addiction Medicine, Behavioral Health and Psychiatry

October 21-23, 2027 | Orlando, Florida, USA

Neurotoxicity of Methamphetamine Use

Neurotoxicity of Methamphetamine Use

Methamphetamine use can cause significant neurotoxicity, leading to long-term cognitive and behavioral impairments. This substance damages dopamine and serotonin systems in the brain, which are vital for mood regulation, reward processing, and motor function. Chronic methamphetamine exposure often results in oxidative stress and inflammation, further harming neural structures. Structural changes in brain regions, such as the prefrontal cortex and basal ganglia, are commonly observed, impairing decision-making and impulse control. These neurotoxic effects can persist even after prolonged abstinence, though some recovery may occur with time and therapeutic interventions. Addressing neurotoxicity through treatments like cognitive rehabilitation and antioxidant therapies is essential for improving the quality of life in affected individuals.

Committee Members
Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2027 - Christopher Ashton

Christopher Ashton

TeDDs on Chapel, Centre for Recovery, Canada
Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2027 - John J Giordano

John J Giordano

Life Enhancement Recovery Center, United States
Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2027 - Sam Vaknin

Sam Vaknin

Commonwealth Institute of Advanced Professional Studies (CIAPS), United Kingdom
Tags

Submit your abstract Today

Whatsapp